124 related articles for article (PubMed ID: 2784568)
21. The role of L3T4 in T cell activation: L3T4 may be both an Ia-binding protein and a receptor that transduces a negative signal.
Tite JP; Sloan A; Janeway CA
J Mol Cell Immunol; 1986; 2(4):179-90. PubMed ID: 3509916
[TBL] [Abstract][Full Text] [Related]
22. Antigen and MHC restriction specificity of two types of cloned male-specific T cell lines.
Tomonari K
J Immunol; 1983 Oct; 131(4):1641-5. PubMed ID: 6194209
[TBL] [Abstract][Full Text] [Related]
23. Activation of Lyt-1+ and Lyt-2+ T cell cloned lines: stimulation of proliferation, lymphokine production, and self-destruction.
Conta BS; Powell MB; Ruddle NH
J Immunol; 1985 Apr; 134(4):2185-90. PubMed ID: 2579131
[TBL] [Abstract][Full Text] [Related]
24. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
Kern DE; Klarnet JP; Cheever MA; Greenberg PD
Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
[TBL] [Abstract][Full Text] [Related]
25. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
Nikolić-Zugić J; Carbone FR
Eur J Immunol; 1990 Nov; 20(11):2431-7. PubMed ID: 2253683
[TBL] [Abstract][Full Text] [Related]
26. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
27. Cloned murine Ia+ BK-BI-2.6.C6 T cells function as accessory cells presenting protein antigens to long-term-cultured antigen-specific T cell lines.
Reske-Kunz AB; Reske K; Rüde E
J Immunol; 1986 Mar; 136(6):2033-40. PubMed ID: 3512709
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
Muraoka S
Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
[TBL] [Abstract][Full Text] [Related]
29. Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones.
Jones B; Tite JP; Janeway CA
J Immunol; 1986 Jan; 136(1):348-56. PubMed ID: 2415625
[TBL] [Abstract][Full Text] [Related]
30. The role of the murine L3T4 molecule in T cell activation: differential effects of anti-L3T4 on activation by monoclonal anti-receptor antibodies.
Janeway CA; Haque S; Smith LA; Saizawa K
J Mol Cell Immunol; 1987; 3(2):121-31. PubMed ID: 2978238
[TBL] [Abstract][Full Text] [Related]
31. Characterization of streptococcal antigen-specific CD8+, MHC class I-restricted, T cell clones that down-regulate in vitro antibody synthesis.
Walker PR; Fellowes R; Hecht EM; Lehner T
J Immunol; 1991 Nov; 147(10):3370-80. PubMed ID: 1834737
[TBL] [Abstract][Full Text] [Related]
32. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide.
Heeg K; Kuon W; Wagner H
Eur J Immunol; 1991 Jun; 21(6):1523-7. PubMed ID: 1904363
[TBL] [Abstract][Full Text] [Related]
33. Lyt-2+ cells. Requirements for concanavalin A-induced proliferation and interleukin 2 production.
Kern DE; Lachmann LB; Greenberg PD
J Immunol; 1987 Nov; 139(9):2880-7. PubMed ID: 2959723
[TBL] [Abstract][Full Text] [Related]
34. Relationship among function, phenotype, and specificity in primary allospecific T cell populations: identification of phenotypically identical but functionally distinct primary T cell subsets that differ in their recognition of MHC class I and class II allodeterminants.
Golding H; Mizuochi T; McCarthy SA; Cleveland CA; Singer A
J Immunol; 1987 Jan; 138(1):10-7. PubMed ID: 2946773
[TBL] [Abstract][Full Text] [Related]
35. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
Kern DE; Klarnet JP; Jensen MC; Greenberg PD
J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to the L3T4 and Lyt-2 molecules interfere with antigen receptor-driven activation of cloned murine T cells.
Moldwin RL; Havran WL; Nau GJ; Lancki DW; Kim DK; Fitch FW
J Immunol; 1987 Aug; 139(3):657-64. PubMed ID: 2955046
[TBL] [Abstract][Full Text] [Related]
37. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
Kovacsovics-Bankowski M; Rock KL
Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
[TBL] [Abstract][Full Text] [Related]
38. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.
Ishioka GY; Colon S; Miles C; Grey HM; Chesnut RW
J Immunol; 1989 Aug; 143(4):1094-100. PubMed ID: 2787356
[TBL] [Abstract][Full Text] [Related]
39. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
Wacholtz MC; Patel SS; Lipsky PE
J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
[TBL] [Abstract][Full Text] [Related]
40. Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells.
Han S; Kim K; Song Y; Kim H; Kwon J; Lee YH; Lee CK; Lee SJ; Ha N; Kim K
Arch Pharm Res; 2008 Mar; 31(3):370-6. PubMed ID: 18409052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
